Dalsania Ankur K, Park Christine M, Nagraj Sanjana, Lorenzatti Daniel, Filtz Annalisa, Weissler-Snir Adaya, Garcia Mario J, Slipczuk Leandro, Schenone Aldo L
Montefiore Einstein Center for Heart & Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
J Clin Med. 2025 Apr 10;14(8):2606. doi: 10.3390/jcm14082606.
Hypertrophic cardiomyopathy remains underdiagnosed despite a growing number of effective treatment interventions that can improve care. Multimodality imaging has become integral to diagnosing and managing hypertrophic cardiomyopathy, providing a comprehensive assessment of the disease. In particular, it enhances the diagnostic accuracy and deepens the understanding of the mechanisms underlying patient symptoms, enabling targeted therapeutic approaches. Additionally, multimodality imaging allows for better risk stratification, assessment of therapy response, and guidance of interventions to deliver personalized medicine. The practical tools outlined in this review can help providers integrate multimodality imaging strategies to provide better care and improve the patient experience.
尽管有越来越多有效的治疗干预措施可以改善肥厚型心肌病的治疗,但该病仍未得到充分诊断。多模态成像已成为诊断和管理肥厚型心肌病不可或缺的手段,能够对该疾病进行全面评估。特别是,它提高了诊断准确性,加深了对患者症状潜在机制的理解,从而实现有针对性的治疗方法。此外,多模态成像有助于更好地进行风险分层、评估治疗反应以及指导干预措施,以提供个性化医疗。本综述中概述的实用工具可帮助医疗服务提供者整合多模态成像策略,以提供更好的治疗并改善患者体验。